新型冠状病毒肺炎疫情防控常态化下门诊药房日常防控措施及工作模式探索

doi:10.19803/j.1672-8629.2022.01.22

中国药物警戒 ›› 2022, Vol. 19 ›› Issue (1): 100-102.
DOI: 10.19803/j.1672-8629.2022.01.22

新型冠状病毒肺炎疫情防控常态化下门诊药房日常防控措施及工作模式探索

赵暄¹, 郭婧², 任爽¹, 甄健存^1,*

¹北京积水潭医院药学部,北京 100035;
²首都医科大学附属复兴医院药剂科,北京 100038

收稿日期:2020-02-25 出版日期:2022-01-15 发布日期:2022-01-20
通讯作者: ^*甄健存,女,本科,主任药师,医院药学和临床药学。E-mail：zhenjiancun@163.com
作者简介:赵暄,男,本科,主管药师,医院药学。

Management and working modes of outpatient pharmacies amid routine COVID-19 epidemic prevention

ZHAO Xuan¹, GUO Jing², REN Shuang¹, ZHEN Jiancun^1,*

¹Department of Pharmacy, Beijing Jishuitan Hospital, Beijing 100035, China;
²Department of Pharmacy, Fuxing Hospital, Capital Medical University, Beijing 100038, China

Received:2020-02-25 Online:2022-01-15 Published:2022-01-20

摘要/Abstract

摘要： 目的在新型冠状病毒肺炎疫情防控常态化下,探索保障医院药学工作顺利开展,及药品在药房各环节中的安全工作模式。方法通过参考相关指南意见及文献,结合医院工作实际情况,明确门诊药房日常工作重点环节的具体防控措施及要点,探索调整工作管理模式。结果研究制订出门诊药房在日常防控措施、工作管理模式等方面的新举措。结论新型冠状病毒肺炎疫情防控常态化下,制定门诊药房日常防控措施及工作管理模式,并在医院工作中得到验证和完善,实现门诊药房药学服务改进。

关键词: 新型冠状病毒肺炎, 疫情防控常态化, 门诊药房, 防控措施, 管理模式

Abstract: Objective To explore the ways in which outpatient pharmacies of hospitals work in order to finish the daily work and ensure the safety of drugs amid the COVID-19 pandemic Methods By reference to the related guidelines and literature and based on the actualities in our hospital, important measures for prevention and control of the pandemic in the daily work of the outpatient pharmacy were clarified. Meanwhile, efforts were made to change the working mode in the outpatient pharmacy. Results In the outpatient pharmacy, some prevention measures were formulated while the working mode was changed accordingly. Conclusion Amid the routine epidemic prevention of COVID-19, the measures that have been taken and changes that have been brought into the working mode in the outpatient pharmacy can ensure the safety of patients and pharmacists. Pharmaceutical care in the outpatient pharmacy has been improved.

Key words: COVID-19, routine epidemic prevention, outpatient pharmacy, management mode, prevention and control measures

中图分类号:

R969.3

赵暄, 郭婧, 任爽, 甄健存. 新型冠状病毒肺炎疫情防控常态化下门诊药房日常防控措施及工作模式探索[J]. 中国药物警戒, 2022, 19(1): 100-102.

ZHAO Xuan, GUO Jing, REN Shuang, ZHEN Jiancun. Management and working modes of outpatient pharmacies amid routine COVID-19 epidemic prevention[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 100-102.

参考文献

[1] General Office of National Health Commission. Novel coronavirus pneumonia control protocol (8th edition)[EB/OL]. (2021-05-14)[2020-06-14]. http://www.nhc.gov.cn/jkj/s3577/202105/6f1e8ec6c4a540d99fafef52fc86d0f8.shtml.
[2] Bureau for Disease Control and Prevention. Announcement of the National Health Commission of the People's Republic of China (No.1, 2020)[EB/OL]. (2020-01-20)[2021-06-14]. http://www.nhe.gov.cn/jkj/s7916/202001/44a3b8245e8049d2837a4f27529cd386.shtml.
[3] WU WY, XIAO X, WU JR.The practice and thinking of pharma-covigilance at the municipal level under COVID-19[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(9): 688-691.
[4] General Office of National Health Commission. Guidelines for novel coronavirus infection prevention and control in healthcare institutions (1st Edition)[EB/OL]. (2020-01-23)[2021-06-14]. http://www.nhe.gov.cn/yzygj/s7659/202001/b91fdab7c304431eb082d67847d27e14.shtml.
[5] General Office of the National Health Commission. Guidelines on the scope of use of common medical protective products in the prevention and control of coronavirus infection (Trial)[EB/OL]. (2020-01-27)[2021-06-13]. http://www.nhe.gov.cn/xcs/zhengcwj/202001/e71c5de925a64eafbe1ce790debab5c6.shtml.
[6] ZHAO RS, YANG YH, YANG L, et al.An outbreak of the SARS-CoV-2 coronavirus: information and pilot guidance for pharmacists and pharmacy workers[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2020, 55(4): 249-267.
[7] CHEN LF, XIAO Y, YU Y, et al.Prevention and control measures of the hospital pharmacy in fever clinic during the coronavirus disease 2019 epidemic[J]. China Pharmaceuticals(中国药业), 2020, 29(5): 18-22.
[8] Ministry of Health, PRC. Measures for waste management in medical and health institutions (Decree No. 36 of the Ministry of Health of the People's Republic of China)[EB/OL]. (2003-10-15)[2021-06-13]. http://www.gov.cn/gongbao/content/2004/content_62768.html.
[9] The State Council of the People's Republic of China. Regulations on management of medical waste(Decree No. 360 of the Ministry of Health of the People's Republic of China)[EB/OL].(2003-06-16)[2021-11-11]. http://www.gov.cn/zhengce/content/2008-03/28/content_6387.htm.

[1]	温都苏, 孙建军, 王毅. 药师参与华法林抗凝治疗对临床安全性和有效性的Meta分析[J]. 中国药物警戒, 2022, 19(9): 1009-1014.
[2]	葛子若, 田地, 王爱彬, 张婷玉, 任兴翔, 钱芳, 李兴旺, 陈志海. 干扰素雾化对新型冠状病毒肺炎的临床治疗分析[J]. 中国药物警戒, 2022, 19(7): 733-739.
[3]	王铁柱. 硫酸羟氯喹致视觉损害不良反应信号检测与分析[J]. 中国药物警戒, 2022, 19(6): 657-660.
[4]	赵暄, 郭婧, 梅隆, 张威. 自动发药系统对门诊药房工作效率和新型冠状病毒肺炎疫情防控的影响分析[J]. 中国药物警戒, 2022, 19(5): 564-567.
[5]	吴作敏, 杨娟, 王隆隆, 王瑞. 黄芪-防风药对治疗新型冠状病毒肺炎的网络药理学研究[J]. 中国药物警戒, 2022, 19(4): 395-399.
[6]	杨帆, 马海平, 尤萌茹, 廖沙, 刘兰, 朱军. 456例新型冠状病毒肺炎患者抗病毒药物应用分析[J]. 中国药物警戒, 2022, 19(4): 413-416.
[7]	郭军, 任丹, 叶龙, 赵荣香, 王宇, 余静. 华法林片致儿童非创伤性自发性肌肉出血1例分析[J]. 中国药物警戒, 2022, 19(3): 339-341.
[8]	熊婧, 刘毅, 刘朝霞, 李婕, 张才煜, 武香香, 何兰. 抗新型冠状病毒肺炎候选药物利托那韦首批国家对照品研制[J]. 中国药物警戒, 2022, 19(2): 137-141.
[9]	李天钰, 贾翌江, 王玉记, 王金辉, 李烨. 新型冠状病毒肺炎治疗药物研究进展[J]. 中国药物警戒, 2022, 19(11): 1266-1271.
[10]	赵喆, 张清, 葛子若, 张伟, 陈志海. 小分子抗新型冠状病毒药物的突破性进展[J]. 中国药物警戒, 2022, 19(1): 1-6.
[11]	熊婧, 严菁, 刘毅, 刘阳, 何兰. 抗新型冠状病毒候选药物法维拉韦首批国家对照品的研制[J]. 中国药物警戒, 2022, 19(1): 52-56.
[12]	丛端端, 赵飞, 薛薇, 李可欣, 胡欣. 基于药物临床试验质量管理规范对新型冠状病毒肺炎相关临床研究的思考和建议[J]. 中国药物警戒, 2021, 18(2): 101-104.
[13]	吴菲, 李民, 方玉婷, 陈泳伍, 沈爱宗. 洛匹那韦利托那韦治疗新型冠状病毒肺炎的不良反应主动监测研究[J]. 中国药物警戒, 2021, 18(2): 105-109.
[14]	吕强, 阎嘉阳, 张旺喆麒, 叶小飞, 郭晓晶. 抗新型冠状病毒肺炎药物磷酸氯喹的安全性分析[J]. 中国药物警戒, 2021, 18(2): 110-114.
[15]	刘枭, 徐银莹, 姜孙旻, 许云. 基于网络药理学和分子对接探讨疏风解毒胶囊治疗新型冠状病毒肺炎可能的作用机制[J]. 中国药物警戒, 2021, 18(2): 115-120.

新型冠状病毒肺炎疫情防控常态化下门诊药房日常防控措施及工作模式探索

Management and working modes of outpatient pharmacies amid routine COVID-19 epidemic prevention

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics